Mesenchymal stem cell-derived secretomes for therapeutic potential of premature infant diseases
© 2020 The Author(s)..
Preterm birth is a complex syndrome and remains a substantial public health problem globally. Its common complications include periventricular leukomalacia (PVL), bronchopulmonary dysplasia (BPD), necrotizing enterocolitis (NEC) and retinopathy of prematurity (ROP). Despite great advances in the comprehension of the pathogenesis and improvements in neonatal intensive care and associated medicine, preterm birth-related diseases remain essentially without adequate treatment and can lead to high morbidity and mortality. The therapeutic potential of mesenchymal stem/stromal cells (MSCs) appears promising as evidenced by their efficacy in preclinical models of pathologies relevant to premature infant complications. MSC-based therapeutic efficacy is closely associated with MSC secretomes and a subsequent paracrine action response to tissue injuries, which are complex and abundant in response to the local microenvironment. In the current review, we summarize the paracrine mechanisms of MSC secretomes underlying diverse preterm birth-related diseases, including PVL, BPD, NEC and ROP, are summarized, and focus is placed on MSC-conditioned media (CM) and MSC-derived extracellular vesicles (EVs) as key mediators of modulatory action, thereby providing new insights for future therapies in newborn medicine.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
---|---|
Enthalten in: |
Bioscience reports - 40(2020), 5 vom: 29. Mai |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wang, Yu [VerfasserIn] |
---|
Links: |
---|
Themen: |
Culture Media, Conditioned |
---|
Anmerkungen: |
Date Completed 23.03.2021 Date Revised 27.03.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.1042/BSR20200241 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM309044529 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM309044529 | ||
003 | DE-627 | ||
005 | 20231225133041.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1042/BSR20200241 |2 doi | |
028 | 5 | 2 | |a pubmed24n1030.xml |
035 | |a (DE-627)NLM309044529 | ||
035 | |a (NLM)32320046 | ||
035 | |a (PII)BSR20200241 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wang, Yu |e verfasserin |4 aut | |
245 | 1 | 0 | |a Mesenchymal stem cell-derived secretomes for therapeutic potential of premature infant diseases |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.03.2021 | ||
500 | |a Date Revised 27.03.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2020 The Author(s). | ||
520 | |a Preterm birth is a complex syndrome and remains a substantial public health problem globally. Its common complications include periventricular leukomalacia (PVL), bronchopulmonary dysplasia (BPD), necrotizing enterocolitis (NEC) and retinopathy of prematurity (ROP). Despite great advances in the comprehension of the pathogenesis and improvements in neonatal intensive care and associated medicine, preterm birth-related diseases remain essentially without adequate treatment and can lead to high morbidity and mortality. The therapeutic potential of mesenchymal stem/stromal cells (MSCs) appears promising as evidenced by their efficacy in preclinical models of pathologies relevant to premature infant complications. MSC-based therapeutic efficacy is closely associated with MSC secretomes and a subsequent paracrine action response to tissue injuries, which are complex and abundant in response to the local microenvironment. In the current review, we summarize the paracrine mechanisms of MSC secretomes underlying diverse preterm birth-related diseases, including PVL, BPD, NEC and ROP, are summarized, and focus is placed on MSC-conditioned media (CM) and MSC-derived extracellular vesicles (EVs) as key mediators of modulatory action, thereby providing new insights for future therapies in newborn medicine | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Review | |
650 | 4 | |a Extracellular vesicles | |
650 | 4 | |a Mesenchymal stem/stromal cells | |
650 | 4 | |a Premature infant disease | |
650 | 4 | |a Secretome | |
650 | 7 | |a Culture Media, Conditioned |2 NLM | |
700 | 1 | |a Long, Wei |e verfasserin |4 aut | |
700 | 1 | |a Cao, Yan |e verfasserin |4 aut | |
700 | 1 | |a Li, Jingyun |e verfasserin |4 aut | |
700 | 1 | |a You, Lianghui |e verfasserin |4 aut | |
700 | 1 | |a Fan, Yuru |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Bioscience reports |d 1981 |g 40(2020), 5 vom: 29. Mai |w (DE-627)NLM01264465X |x 1573-4935 |7 nnns |
773 | 1 | 8 | |g volume:40 |g year:2020 |g number:5 |g day:29 |g month:05 |
856 | 4 | 0 | |u http://dx.doi.org/10.1042/BSR20200241 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 40 |j 2020 |e 5 |b 29 |c 05 |